To include your compound in the COVID-19 Resource Center, submit it here.

Theravance Biopharma sales and marketing update

Theravance said it has launched Vibativ telavancin in a limited number of geographic territories in the U.S during the past year and now is planning a targeted

Read the full 273 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE